Open AccessResponse to growth hormone in patients with RNPC 3 mutations
Author(s) -
MartosMoreno Gabriel Á,
TraviesoSuárez Lourdes,
PozoRomán Jesús,
MuñozCalvo María T,
Chowen Julie A,
Frilander Mikko J,
PérezJurado Luis A,
Hawkins Federico G,
Argente Jesús
Publication year - 2018
Publication title -
embo molecular medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.923
H-Index - 107
eISSN - 1757-4684
pISSN - 1757-4676
DOI - 10.15252/emmm.201809143
Subject(s) - medicine , pediatric endocrinology , humanities , pediatrics , library science , art , computer science
After 6 years of Growth Hormone ( GH ) therapy, three patients with a defect in minor spliceosome mRNA processing leading to an incompletely understood GH deficit present with excellent auxological response and improvement in the bone mineral density and trabecular bone structure.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom